本頁面由Tiger Trade Technology Pte. Ltd.提供服務

HCW Biologics Inc.

1.22
+0.8830262.02%
盤後1.03-0.1897-15.55%19:59 EDT
成交量:3.95億
成交額:4.38億
市值:821.56萬
市盈率:-0.11
高:1.42
開:1.11
低:0.9910
收:0.3370
52周最高:10.00
52周最低:0.2500
股本:673.41萬
流通股本:288.32萬
量比:54.69
換手率:13697.40%
股息:- -
股息率:- -
每股收益(TTM):-10.6300
每股收益(LYR):-30.9580
淨資產收益率:-27725.96%
總資產收益率:-31.19%
市淨率:2.97
市盈率(LYR):-0.04

資料載入中...

2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/14

重要事件披露

Form 8-K - Current report
2026/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/24

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/04/23

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/04/17

重要事件披露

Form 8-K - Current report
2026/03/31

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/31

重要事件披露

Form 8-K - Current report
2026/03/17

重要事件披露

Form 8-K - Current report
2026/03/02

重要事件披露

Form 8-K - Current report
2026/02/19

重要事件披露

Form 8-K - Current report
2026/02/17

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/02/13

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/02/13

重要事件披露

Form 8-K - Current report
2026/02/12

SEC問詢函

Form CORRESP - Correspondence
2026/02/12

SEC問詢函

Form CORRESP - Correspondence
2026/02/11

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/01/09

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933